PEGS: The Essential Protein Engineering Summit is one of the industry’s most preeminent events that inspires accelerated biotherapeutic protein drug development.

Cancer Biotherapy and Radiopharmaceuticals provides peer-reviewed research on cutting-edge therapeutic investigations and advancements in radioimmunotherapy for treating cancer. It is the only journal with the specific focus of cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapies.

Pick up your copy of this essential resource at the PEGS.